← Open Payments lookup

MICHELLE KUEHN: Open Payments

NPI 1538882022 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$358 in 18 payments from 12 companies in 2025. Trend: 2023 $74 · 2024 $141 · 2025 $358

Food & beverage: $358
CompanyPaymentsAmount
ABBVIE INC.3$58
Lilly USA, LLC3$58
Novo Nordisk Inc3$52
Tonix Medicines, Inc.1$33
Vanda Pharmaceuticals Inc.1$25
GlaxoSmithKline, LLC.1$21
Sumitomo Pharma America, Inc.1$20
VERTEX PHARMACEUTICALS INCORPORATED1$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
AstraZeneca Pharmaceuticals LP1$19

Products named: Ozempic, VRAYLAR, TONMYA, MOUNJARO, JARDIANCE, HETLIOZ, TRELEGY ELLIPTA, GEMTESA.

Industry payments across NE — which companies pay providers there.